BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37084489)

  • 21. Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells.
    Fukushima K; Otagaki S; Takahashi K; Minami K; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
    J Recept Signal Transduct Res; 2018 Aug; 38(4):367-371. PubMed ID: 30396320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysophosphatidic acid receptor-2 (LPA
    Takahashi K; Minami K; Otagaki S; Ishimoto K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2698-2703. PubMed ID: 30093116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.
    Hayashi M; Okabe K; Kato K; Okumura M; Fukui R; Fukushima N; Tsujiuchi T
    Cancer Lett; 2012 Mar; 316(1):91-6. PubMed ID: 22079467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
    Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
    J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
    Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
    Yamauchi A; Yamamura M; Katase N; Itadani M; Okada N; Kobiki K; Nakamura M; Yamaguchi Y; Kuribayashi F
    BMC Cancer; 2017 Mar; 17(1):234. PubMed ID: 28359316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysophosphatidic acid (LPA) signaling via LPA
    Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bisphenol A and 4-nonylphenol on cellular responses through the different induction of LPA receptors in liver epithelial WB-F344 cells.
    Dong Y; Araki M; Hirane M; Tanabe E; Fukushima N; Tsujiuchi T
    J Recept Signal Transduct Res; 2014 Jun; 34(3):201-4. PubMed ID: 24460192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of LPA receptor-5 in the enhancement of cell motile activity by phorbol ester and anticancer drug treatments in melanoma A375 cells.
    Fukushima K; Takahashi K; Kurokawa A; Ishimoto K; Otagaki S; Minami K; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2018 Jan; 496(1):225-230. PubMed ID: 29309788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of LPA1 on cell motile activities stimulated by hydrogen peroxide and 2,3-dimethoxy-1,4-naphthoquinone in fibroblast 3T3 cells.
    Hirane M; Araki M; Dong Y; Honoki K; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2013 Nov; 441(1):47-52. PubMed ID: 24134844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of LPA
    Takahashi K; Fukushima K; Otagaki S; Ishimoto K; Minami K; Fukushima N; Honoki K; Tsujiuchi T
    J Recept Signal Transduct Res; 2018 Feb; 38(1):71-75. PubMed ID: 29369010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells.
    Yoshikawa K; Tanabe E; Shibata A; Inoue S; Kitayoshi M; Okimoto S; Fukushima N; Tsujiuchi T
    Exp Cell Res; 2013 Feb; 319(3):105-12. PubMed ID: 23041208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogen peroxide stimulates cell motile activity through LPA receptor-3 in liver epithelial WB-F344 cells.
    Shibata A; Tanabe E; Inoue S; Kitayoshi M; Okimoto S; Hirane M; Araki M; Fukushima N; Tsujiuchi T
    Biochem Biophys Res Commun; 2013 Apr; 433(3):317-21. PubMed ID: 23510996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells.
    Okabe K; Hayashi M; Kato K; Okumura M; Fukui R; Honoki K; Fukushima N; Tsujiuchi T
    Mol Carcinog; 2013 Apr; 52(4):247-54. PubMed ID: 22161812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of lysophosphatidic acid (LPA) receptor-mediated signaling in breast cancer cell functions by long-term tamoxifen treatment under hypoxic and estrogen-deprived conditions.
    Takai M; Yamamoto M; Yashiro N; Tsujiuchi T
    Pathol Res Pract; 2024 Jun; 260():155385. PubMed ID: 38875757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.
    Fukui R; Tanabe E; Kitayoshi M; Yoshikawa K; Fukushima N; Tsujiuchi T
    Tumour Biol; 2012 Dec; 33(6):1899-905. PubMed ID: 22763559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
    Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
    J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
    Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
    Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.